Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Health Indicator Report of Prostate Cancer Deaths

Prostate cancer is the second most commonly occurring form of cancer for men, after skin cancer, and is the second leading cause of cancer death for men in Utah and the U.S.

Prostate Cancer Deaths by Utah Small Area, 2011-2015

Notes

ICD-10 codes used to define prostate cancer: C61.   [[br]] Age-adjusted to U.S. 2000 standard population. [[br]] [[br]] *Use caution when interpreting, the estimate has a relative standard error greater than 30% and is therefore does not meet Utah Department of Health standards for reliability. [[br]] **The estimate has been suppressed because 1) the relative standard error is greater than 50% or the relative standard error can't be determined or 2) the observed number of events is very small and not appropriate for publication.[[br]] [[br]] ^Due to Utah Small Area reclassification, numbers for 'West Valley (East)', 'Kearns', and 'West Jordan (NE)' only include data for 2011 and numbers for 'West Valley (East) V2', 'Kearns V2', 'Taylorsville (West)', and 'West Jordan (NE) V2' only include data for 2012-2015.[[br]] [[br]] A description of the Utah Small Areas and details about Small Area reclassification may be found on IBIS at the following URL: [http://ibis.health.utah.gov/resource/Help.html].

Data Sources

  • Utah Death Certificate Database, Office of Vital Records and Statistics, Utah Department of Health
  • Population estimates produced by the UDOH Center for Health Data and Informatics. Linear interpolation of U.S. Census Bureau and ESRI ZIP Code data provided annual population estimates for ZIP Code areas by sex and age groups, IBIS Version 2015

Definition

The rate of death from cancer of the prostate (ICD-10: C61) per 100,000 men.

Numerator

The number of deaths due to prostate cancer for a given year (ICD-10: C61).

Denominator

The male population in Utah or the U.S. for a given year.

Healthy People Objective C-7:

Reduce the prostate cancer death rate
U.S. Target: 21.8 deaths per 100,000 males

Other Objectives

CSTE Chronic Disease Indicators

How Are We Doing?

In 2015, Utah's age-adjusted prostate cancer mortality rate was 17.4 per 100,000 males. There was no significant difference in prostate cancer mortality among Utah's ethnic or racial groups, with the exception of Utah Asians having significantly lower rates than all races combined.

How Do We Compare With the U.S.?

The U.S. prostate cancer age-adjusted mortality rate has been decreasing. Utah's prostate cancer age-adjusted mortality rate has varied from year-to-year and have closely mirrored national rate.[[br]][[br]] In 2015, Utah's age-adjusted prostate cancer mortality rate was 17.4 per 100,000 males while the national rate was 18.8 per 100,000 males.

What Is Being Done?

The Utah Department of Health initiated the Utah Cancer Action Network (UCAN), a statewide partnership whose goal is to reduce the burden of cancer. The mission of the UCAN is to lower cancer incidence and mortality in Utah through collaborative efforts directed toward cancer prevention and control. As a result of this planning process, objectives and strategies have been developed by community partners regarding the early detection of cervical, breast, and colorectal cancers as well as the promotion of physical activity, healthy eating habits, melanoma cancer prevention, and cancer survivorship advocacy.

Evidence-based Practices

Screening recommendations have changed over time. Until recently, many doctors and professional organizations encouraged yearly PSA screening for men beginning at age 50. However, as more has been learned about both the benefits and harms of prostate cancer screening, a number of organizations have begun to caution against routine population screening. Although some organizations continue to recommend PSA screening, there is widespread agreement that any man who is considering getting tested should first be informed in detail about the potential harms and benefits. Since 2012 the U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer. Healthy diet, exercise, and lifestyle play an important role in cancer prevention.

Available Services

Currently, Medicare provides coverage for an annual PSA test for all Medicare-eligible men age 50 and older. Many private insurers cover PSA screening as well.
Page Content Updated On 05/23/2017, Published on 05/26/2017
The information provided above is from the Department of Health's Center for Health Data IBIS-PH web site (http://ibis.health.state.gov). The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Wed, 18 July 2018 2:54:00 from Department of Health, Center for Health Data, Indicator-Based Information System for Public Health Web site: http://ibis.health.state.gov ".

Content updated: Thu, 12 Oct 2017 16:34:14 MDT